Tezcan Gecgil

Tezcan Gecgil

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

3 VIX ETFs To Trade Looming Election Volatility

Here are several VIX ETFs that offer exposure to volatility ahead of the U.S. Presidential election.

7 Innovative Stocks That Will Disrupt Their Sectors

These seven innovative stocks, and ETFs that hold such stocks, could have significant growth potential in the months ahead.

7 Index Funds to Hold Through Thick and Thin

Index funds offer immediate diversification and access to a wide range of stocks. Here are several of the best index funds that could be suitable for a wide range of investing styles.

How Gores Metropoulos May Help Portfolios Drive Forward

Lidar technology may fuel GMHI stock to new highs in the months ahead after the SPAC combines with Luminar and begins trading on the Nasdaq.

SPAQ Stock Is Likely To Be Volatile In October

Long-term investors may consider waiting before investing in SPAQ stock

7 Biotech Stocks To Buy For Profit From The Vaccine Crunch

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.

Apple Is Under Pressure and May See $100 Before $140

Although AAPL stock has probably peaked for now, long-term investors in Apple may consider buying the dips.

The 7 Best New Stocks From 2020 to Buy Now

IPO stocks offer all sorts of risks and rewards. Here are seven new stocks to buy that represent the best of both worlds.

7 Vanguard ETFs Everyone Should Consider

If you like low cost funds and diversification, here are seven Vanguard ETFs to buy

Disney Stock Is Way More Likely to See $115 Before It Sees $150

Disney stock is trading close to 20% below the all-time high set in November 2019. There could still be some more pain for DIS shares